Hypofractionated Radiotherapy for Lung Cancer



Status:Completed
Conditions:Lung Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:June 2004
End Date:December 2012

Use our guide to learn which trials are right for you!

The Use of Helical Tomotherapy to Achieve Dose-per-fraction Escalation in Lung Cancer

The purpose of this trial is to pilot reducing the duration of radiation treatment for lung
cancer patients from 6 to 5 weeks using tomotherapy. Specific patient doses will be based on
tumor volume being treated. Modeling has shown that increased biologically effective dose
(BED) to tumors can be achieved by shortening the radiation delivery schedule and increasing
the dose per fraction. This requires decreasing the total dose to hold lung toxicity
constant at each dose per fraction level. This is a major paradigm shift in the treatment in
this disease and is projected to result in significant improvements in patient outcome as
well as a substantial cost savings.


Inclusion Criteria:

- Thoracic neoplasm requiring at lest 60 Gy conventional radiotherapy

Exclusion Criteria:

- Prior bleomycin or gemcitabine chemotherapy

- Prior thoracic radiotherapy
We found this trial at
1
site
600 Highland Ave
Madison, Wisconsin 53792
(608) 263-6400
University of Wisconsin Hospital and Clinics UW Health strives to meet the health needs of...
?
mi
from
Madison, WI
Click here to add this to my saved trials